Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

INDUSTRY 37OTHER 28NIH 18NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 37Genitourinary 24Thoracic 17Gynecologic 16Lymphoid 12Sarcoma 6Breast 4Head & Neck 3Other solid neoplasm 2Tumor-Agnostic 1Other hematologic neoplasm 1

Conditions

Mesothelioma, Malignant 2Solitary Fibrous Tumor, Pleural 1Mesothelioma 1

Interventions

Cisplatin 6Pemetrexed 5Carboplatin 4Standard of Care 3Specimen Handling 3Practice Guidelines as Topic 3Interviews as Topic 3Immunoenzyme Techniques 3Docetaxel 3raltitrexed 2Vincristine 2Trabectedin 2N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide 2Irinotecan 2Immunohistochemistry 2Gemcitabine 2Etoposide 2Early Intervention, Educational 2Bortezomib 2AEG 35156 2temsirolimus 1sabarubicin 1pembrolizumab 1nintedanib 1halofuginone 1ascrinvacumab 1Triptorelin Pamoate 1Thrombopoietin 1Theophylline 1SB939 compound 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Gemcitabine × Other solid neoplasm × Clear all
NCT00101283 2023-07-03

Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma

Eastern Cooperative Oncology Group

Phase 2 Completed
32 enrolled 8 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT00003723 2012-10-08

S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery

SWOG Cancer Research Network

Phase 2 Completed
57 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

Data powered by HemOnc (CC BY 4.0) Colophon âš¡